Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.58 - $13.94 $645,070 - $1.61 Million
115,604 New
115,604 $1.41 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $287,230 - $537,262
47,087 Added 83.66%
103,368 $657,000
Q2 2022

Aug 15, 2022

BUY
$6.61 - $11.99 $11,693 - $21,210
1,769 Added 3.25%
56,281 $506,000
Q1 2022

May 11, 2022

BUY
$11.56 - $17.9 $289,104 - $447,661
25,009 Added 84.77%
54,512 $630,000
Q4 2021

Feb 11, 2022

BUY
$17.36 - $27.36 $79,612 - $125,472
4,586 Added 18.41%
29,503 $519,000
Q3 2021

Nov 12, 2021

BUY
$22.34 - $39.1 $556,645 - $974,254
24,917 New
24,917 $566,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $178M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.